Ergoresearch becomes the reference for the evaluation of knee pain in Quebec

Saturday, March 11, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

LAVAL, QC, March 10, 2017 /CNW Telbec/ -With the support of Ergoresearch, ノquilibre葉he largest network of orthotists

in Quebec, announces the adoption of the latest cutting-edge technology in the management of knee pain: KneeKGTM, whichexpands the evaluation services it offers in its clinics and knee centres.

With

the goal of providing an effective, personalized plan of treatment, ノquilibre now provides complete and precise diagnostic evaluation services for the knee. This unique approach is made possible by KneeKG technology, which measures objective, standardized data while the patient is in movement. "KneeKGTM represents a real revolution in the examination of the knee, as the precision of the technology permits the optimization of the plan of treatment. This means that the patient gains better quality of life and is able to be more mobile, which fully aligns with our mission", says Sylvain Boucher, President and CEO of Ergoresearch.

The data gathered by KneeKGTM provide the basis for an interdisciplinary approach with specialists from ノquilibre (kinesiologists, physical readaptation technicians, orthotists), as well as the treating physician, physiotherapists, and other Quebec healthcare professionals.

KneeKGTM was created in 2007 and is the result of 12 years of research at 3 universities in Quebec (ノcole de Technologie Sup駻ieure, centre de recherch du CHUM at Universit de Montr饌l, and ノcole Polytechnique) and the company Emovi. This system for the 3D analysis of anomalies of the knee received important support from the international medical community which benefits significantly from the new technology. In Quebec, Dr Pierre Ranger, orthopedic surgeon and chief of the orthopedic department at Jean-Talon hospital says: "The advantage of this technology is that it helps us diagnose problems of the knee and gives us relevant information to establish a plan of treatment and follow patients once they implement the plan."

Emovi, the Quebec-based company that markets KneeKGTM technology, is enthusiastic about the new partnership. "We are very pleased with our collaboration with ノquilibre and its impressive network of clinics that will provide greater access to this examination tool throughout Quebec" mentions Alexandre Fuentes, vice-president for clinical affairs at Emovi.

A new program, "I'm taking care of my arthrosis", which accompanies KneeKGTM will be spearheaded in Quebec by Ergoresearch who, while implementing the new technology, will also provide complete multidisciplinary care including therapist-supervised and personalized exercise programs.

This program is unique in Quebec and is grounded in the physical participation of each patient in their therapy. "We are proud to be able to contribute to the growth of Quebec-designed technology and to promote an interdisciplinary approach within our organization預nd all this, with the goal of providing our patients with the best possible quality of life", adds Mr. Boucher.

About Ergoresearch

Ergoresearch is a Canadian company that designs and manufactures cutting edge technologies and solutions for the orthopedic industry. The company is listed on the Toronto Stock Exchange and trades under the symbol"ERG". With a portfolio of patents relating toorthopedics and human bionics, the company is a leader in the creation of custom-made orthotic devices. Ergoresearch has also developed the most influential network of orthotist clinics in Quebec, under the banner "ノquilibre", with over 70 clinics and points of service throughout Quebec.

About ノquilibre

ノquilibre熔rthotic devices ("braces") andbiomechanics, is the largest network of orthotists in Quebec, which provides a host of biomechanic device solutions. Driven by wide-ranging innovationand the expertise of healthcare professionals, ノquilibre's mission is to get people moving by reducing pain, rehabilitating motor functions and optimizing performance. Thanks to its 70 clinics and points of service, ノquilibre is now found in all corners of Quebec.

About Emovi

Emovi is a Quebec company that provides medical solutions for the knee articulation. With partners in university research centres throughout Quebec, including the CRCHUM and ノcole de technologie sup駻ieure (ノTS),

Emovi developed KneeKGTM which identifies biomechanical deficiencies that cause pain and disabilities.

This new technology has already provided relief to a large number of patients suffering from pathologies of the knee including arthrosis, meniscal tear and torn ligaments, patellofemoral syndrome, tendinitis, etc. KneeKGTM is now available in Canada, the US, France, Switzerland, China and Australia.

This communication does not aim to encourage thepurchase of shares on the Toronto Stock Exchange. Neither TMX Group Limited nor any of its affiliated companies endorses or recommend the shares in question. Please obtain the advice of a specialist to evaluate specific shares.

SOURCE Ergoresearch Ltd



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook